A passion for outthinking cancer
Eric, Associate Director at Merrimack
Our collaborations

Innovation doesn’t happen alone.
Learn more about teaming with Merrimack.

Learn more

News

View all news
September 20, 2018

Merrimack Receives $5 Million Milestone Payment from Shire

Read more
September 06, 2018

Merrimack Completes Enrollment in Randomized Phase 2 SHERLOC Study of MM-121 (seribantumab) in Non-Small Cell Lung Cancer (NSCLC)

Read more
August 07, 2018

Merrimack Reports Second Quarter 2018 Financial Results

Read more
July 31, 2018

Merrimack Announces Timing of Second Quarter 2018 Investor Conference Call

Read more

Social Media

Follow us on Twitter

September 20, 2018
@MerrimackPharma
Today we announced the receipt of a $5 million milestone payment from Shire. Read more in the full release: http://iUuTvZ0Smp

September 20, 2018
@MerrimackPharma
Our vision is to see a world where all cancer patients and their families can live fulfilling lives. http://fgRfQ3xXwS